Targeting BMI-1 in B cells restores effective humoral immune responses and controls chronic viral infection.
Nat Immunol
; 23(1): 86-98, 2022 01.
Article
en En
| MEDLINE
| ID: mdl-34845392
ABSTRACT
Ineffective antibody-mediated responses are a key characteristic of chronic viral infection. However, our understanding of the intrinsic mechanisms that drive this dysregulation are unclear. Here, we identify that targeting the epigenetic modifier BMI-1 in mice improves humoral responses to chronic lymphocytic choriomeningitis virus. BMI-1 was upregulated by germinal center B cells in chronic viral infection, correlating with changes to the accessible chromatin landscape, compared to acute infection. B cell-intrinsic deletion of Bmi1 accelerated viral clearance, reduced splenomegaly and restored splenic architecture. Deletion of Bmi1 restored c-Myc expression in B cells, concomitant with improved quality of antibody and coupled with reduced antibody-secreting cell numbers. Specifically, BMI-1-deficiency induced antibody with increased neutralizing capacity and enhanced antibody-dependent effector function. Using a small molecule inhibitor to murine BMI-1, we could deplete antibody-secreting cells and prohibit detrimental immune complex formation in vivo. This study defines BMI-1 as a crucial immune modifier that controls antibody-mediated responses in chronic infection.
Texto completo:
1
Base de datos:
MEDLINE
Asunto principal:
Linfocitos B
/
Proteínas Proto-Oncogénicas
/
Inmunidad Humoral
/
Complejo Represivo Polycomb 1
/
Coriomeningitis Linfocítica
/
Virus de la Coriomeningitis Linfocítica
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Nat Immunol
Asunto de la revista:
ALERGIA E IMUNOLOGIA
Año:
2022
Tipo del documento:
Article